title: Downregulation of free ubiquitin: a novel mechanism of p53 stabilization and neuronal cell death.
abstract: Neuronal death through activation of the p53 stress response pathway has been implicated in the pathogenesis of neurodegenerative disorders. The mechanisms regulating p53 accumulation and function in neurons are poorly understood. Recent evidence has demonstrated that Mdm2 is a major inhibitor of p53 that binds to and targets p53 for ubiquitin-mediated degradation. Here we demonstrate increased expression and co-localization of p53 and Mdm2 in the nuclei of degenerating neurons following treatment with either the excitotoxin, kainic acid, or the topoisomerase I inhibitor, camptothecin. Co-immunoprecipitation studies showed that p53-Mdm2 complexes were present in neuronal lysates. Dual immunofluorescence microscopy demonstrated that these complexes accumulated in neurons with a striking decrease in free ubiquitin levels. Exogenous ubiquitin restored p53 degradation to extracts from injured neurons confirming that Mdm2 function was intact. Finally, antisense-mediated downregulation of ubiquitin in cultured hippocampal neurons resulted in p53 and Mdm2 accumulation as well as apoptotic death. These results point to a novel mechanism to stabilize p53 and promote neuronal cell death in the central nervous system.
authors.affiliation: Department of Neurology, University of Southern California, Keck School of Medicine, Los Angeles, CA 90033, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Tan
authors.forename: W
authors.initials: W
authors.lastname: Tu
authors.forename: S S
authors.initials: SS
authors.lastname: Schreiber
mesh_terms: D000818:Animals; D001921:Brain / Q000166:cytology; D002166:Camptothecin / Q000494:pharmacology; D016923:Cell Death / Q000502:physiology*; D002478:Cells, Cultured; D004249:DNA Damage; D015536:Down-Regulation / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D018690:Excitatory Amino Acid Agonists; D020287:In Situ Nick-End Labeling; D007608:Kainic Acid; D008297:Male; D009410:Nerve Degeneration / Q000139:chemically induced / Q000378:metabolism; D009474:Neurons / Q000166:cytology* / Q000378:metabolism*; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051736:Proto-Oncogene Proteins c-mdm2; D051381:Rats; D017207:Rats, Sprague-Dawley; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D014452:Ubiquitins / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D018690:Excitatory Amino Acid Agonists; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; D016159:Tumor Suppressor Protein p53; D014452:Ubiquitins; C497208:Mdm2 protein, rat; D051736:Proto-Oncogene Proteins c-mdm2; D007608:Kainic Acid; D002166:Camptothecin